Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population

Clinica Chimica Acta

Volumn 351, Issue 1-2, 2005, Pages 87-94

  Berdeli, Afig ^a   Sekuri, Cevad ^b,e   Sirri Cam, F ^b   Ercan, Ertugrul ^c   Sagcan, Abdi ^d   Tengiz, Istemihan ^c   Eser, Erhan ^b   Akin, Mustafa ^a  

^a EGE UNIVERSITY   (Turkey)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c Central Hospital Izmir   (Turkey)

^d Atakalp Kalp Hastaliklari Hastanesi Kahramanlar   (Turkey)

^e Dept of Pub Health Manisa Turkey ^*  (Turkey)

Author keywords

Endothelial nitric oxide synthase; Gene polymorphism; Premature coronary artery disease; Renin angiotensin system

Indexed keywords

NITRIC OXIDE SYNTHASE; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ADULT; AGE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

ADULT; AGE OF ONSET; AMINO ACID SUBSTITUTION; ARTERIOSCLEROSIS; CORONARY ARTERIOSCLEROSIS; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; TURKEY;

EID: 9444243209     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.08.015     Document Type: Article

References (45)

1. M.A. Gimbrone Jr. Vascular endothelium, hemodynamic forces, and atherogenesis Am. J. Pathol. 155 1999 1 5
2. H. Rakugi, D.K. Kim, J.E. Krieger, D.S. Wang, V.J. Dzay, and R.E. Pratt Induction of angiotensin converting enzyme in the neointima after vascular injury: possible role in restenosis J. Clin. Invest. 93 1994 339 346
3. H. Nishimura, H. Tsuji, and H. Masuda The effects of angiotensin metabolites on the regulation of coagulation and fibrinolysis in cultured rat aortic endothelial cells Thromb. Haemost. 82 1999 1516 1521
4. B. Rigat, C. Hubert, P. Corvol, and F. Soubrier PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1) Nucleic Acids Res. 20 1992 1433
5. B. Rigat, C. Hubert, F. Alhenc-Gelas, F. Cambien, P. Corvol, and F. Soubrier An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J. Clin. Invest. 86 1990 1343 1346
6. K.K. Griendling, T.J. Murphy, and W.J. Alexander Molecular biology of the renin-angiotensin system Circulation 87 1993 1816 1828
7. T. Katsuya, G. Koike, and T.W. Yee Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease Lancet 345 1995 1600 1603
8. L. Tiret, A. Bonnardeaux, and O. Poirier Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor DD genotype of the gene polymorphisms on risk of myocardial infarction Lancet 344 1994 910 913
9. C.M. Boulanger, L. Caputo, and B.I. Levy Endothelial AT1-mediated release of nitric oxide decreases angiotensin II contractions in rat carotid artery Hypertension 26 1995 752 757
10. U. Ikeda, Y. Maeda, Y. Kawahara, M. Yokoyama, and K. Shimada Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes Circulation 92 1995 2683 2689
11. S. Moncada, and A. Higgs The l-arginine-nitric oxide pathway N. Engl. J. Med. 329 1993 2002 2012
12. T.F. Luscher The endothelium as a target and mediator of cardiovascular disease Eur. J. Clin. Investig. 23 1993 670 685
13. R. Sarkar, E.G. Meinberg, J.C. Stanley, D. Gordon, and R.C. Webb Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells Circ. Res. 78 1996 225 230
14. U.C. Garg, and A. Hassid Nitric oxide-generating vasodilatators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells J. Clin. Invest. 83 1989 1774 1777
15. N. Hogg, B. Kalyanaraman, J. Joseph, A. Struck, and S. Parthasarathy Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis FEBS Lett. 334 1993 170 174
16. A.D. Hingorani, C.F. Liang, and J. Fatibene A common variant of the endothelial nitric oxide synthase (Glu298-Asp) is a major risk factor for coronary artery disease in the UK Circulation 100 1999 1515 1520
17. P.A. Marsden, H.H. Heng, and S.W. Scherer Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene J. Biol. Chem. 268 1993 17478 17488
18. G.P. Rossi, T.M. Seccia, and G.G. Nussdorfer Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system Int. Rev. Cytol. 209 2001 241 272
19. P.J. Andrew, and B. Mayer Enzymatic function of nitric oxide synthases Cardiovasc. Res. 43 1999 521 531
20. A.D. Hingorani Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000 Atherosclerosis 154 2001 521 527
21. Y. Miyamoto, Y. Saito, and N. Kajiyama Endothelial nitric oxide synthase gene is positively associated with essential hypertension Hypertension 32 1998 3 8
22. Y. Shimasaki, H. Yasue, and M. Yoshimura Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction J. Am. Coll. Cardiol. 31 1998 1506 1510
23. K. Hibi, T. Ishigami, and K. Tamura Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction Hypertension 32 1998 521 526
24. M. Yoshimura, H. Yasue, and M. Nakayama A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese Hum. Genet. 103 1998 65 69
25. M. Tesauro, W.C. Thompson, P. Rogliani, L. Qi, P.P. Chaudhary, and J. Moss Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298 Proc. Natl. Acad. Sci. 97 6 2000 2832 2835
26. J.P. Cooke Role of nitric oxide in progression and regression of atherosclerosis West J. Med. 164 1996 419 424
27. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease Circulation 59 1979 607 608
28. V. Shanmugam, K.W. Sell, and B.K. Saha Mistyping ACE heterozygotes PCR Methods Appl. 3 1993 120 121
29. M. Caulfield, P. Lavander, and M. Farrall Linkage of the angiotensinogen gene to essential hypertension N. Engl. J. Med. 330 1994 1629 1633
30. R. Alvarez, J.R. Reguero, and A. Batalla Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphisms: association with early coronary disease Cardiovasc. Res. 40 1998 375 379
31. Turkish Heart Report 2000, Turkish Society of Cardiology, Yenilik Publication, 11-25, Istanbul.
32. E.R. Hauser, V. Mooser, and D.C. Crossman Design of the genetics of early onset cardiovascular disease (GENECARD) study Am. Heart J. 145 2003 602 613
33. M.C. Roncaglioni, L. Santoro, and L. D'Avanzo Role of family history in patients with myocardial infarction: an Italian Case-Control study. GISSIEFRIM Investigators Circulation 85 1992 2065 2072
34. R.A. Nishimura, D.R. Holmes Jr., A.L. Lerman, J. Suwaidi, S. Hamasaki, and S. Higano Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction Circulation 101 2000 948 954
35. C. Fatini, R. Abbate, and G. Pepe Searching for a better assessment of the individual coronary risk profile. The role of angiotensin-converting enzyme, angiotensin II type 1 receptor and angiotensinogen gene polymorphisms Eur. Heart J. 21 2000 633 638
36. D. Petrovic, M. Zorc, V. Kanic, and B. Peterlin Interaction between gene polymorphisms of renin-angiotensin system and metabolic risk factors in premature myocardial infarction Angiology 52 2001 247 252
37. N. Fernandez-Arcas, J.L. Dieguez-Lucena, and E. Munoz-Moran Both alleles of the M235T polymorphism of the angiotensinogen gene can be a risk factor for myocardial infarction Clin. Genet. 60 2001 52 57
38. X. Jeunemaitre, F. Ledru, and S. Battaglia Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE Study Hum. Genet. 99 1997 66 73
39. S. Ichihara, M. Yokota, and T. Fujimura Lack of association between variants of the angiotensinogen gene and the risk of coronary artery disease in middle-aged Japanese men Am. Heart J. 134 1997 260 265
40. O. Aras, N.Q. Hanson, S.M. Bakanay, My Tsai, and S. Gulec Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population Thromb. Haemost. 87 2002 347 349
41. J. Karvonen, H. Kauma, and K. Kervinen Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort J. Intern. Med. 251 2 2002 (Feb.) 102 110
42. B.A. Nassar, L.D. Bevin, and D.E. Johnstone Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early-onset coronary artery disease Am. Heart J. 142 4 2001 (Oct) 586 589
43. A. Batalla, R. Alvarez, and J.R. Reguero Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction Clin. Chem. 46 12 2000 1910 1915
44. H. Nakagami, U. Ikeda, and Y. Maeda Coronary artery disease and endothelial nitric oxide synthase and angiotensin-converting enzyme gene polymorphisms J. Thromb. Thrombolysis 8 1999 191 195
45. R. Alvarez, P. Gonzalez, and A. Batalla Association between the NOS3(-786T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease Nitric Oxide 5 2001 343 348